| UNITED STATES | OMB APPROVAL | |
| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB Number: 3235-0582 | |
| Expires: July 31, 2024 | ||
| Estimated average burden hours per response........4 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-8767
UBS Series Funds
(Exact name of registrant as specified in charter)
| 787 Seventh Avenue New York, New York | 10019-6028 | |
| (Address of principal executive offices) | (Zip code) |
Eric Sanders
UBS Asset Management (Americas) Inc.
787 Seventh Avenue
New York, NY 10019
Registrant’s telephone number, including area code: 888-793-8637
Date of fiscal year end: 4/30
Date of reporting period: 7/1/2022 – 6/30/2023
Item 1. Proxy Voting Record.
******************************* FORM N-Px REPORT ******************************* ICA File Number: 811-8767 UBS Series Funds 787 Seventh Avenue New York, NY 10019 888-793-8637 Eric Sanders UBS Asset Management (Americas) Inc. 787 Seventh Avenue New York, NY 10019 Fiscal year end: 4/30 Reporting Period: 07/01/2022 - 06/30/2023 ===================== Limited Purpose Cash Investment Fund ===================== Did not vote any securities during the reporting period ====================== UBS Liquid Assets Government Fund ======================= Did not vote any securities during the reporting period =========================== UBS Prime Investor Fund ============================ Did not vote any securities during the reporting period =========================== UBS Prime Preferred Fund =========================== Did not vote any securities during the reporting period =========================== UBS Prime Reserves Fund ============================ Did not vote any securities during the reporting period ===================== UBS RMA Government Money Market Fund ===================== Did not vote any securities during the reporting period =================== UBS Select ESG Prime Institutional Fund ==================== Did not vote any securities during the reporting period ====================== UBS Select ESG Prime Investor Fund ====================== Did not vote any securities during the reporting period ===================== UBS Select ESG Prime Preferred Fund ====================== Did not vote any securities during the reporting period =================== UBS Select Government Institutional Fund =================== Did not vote any securities during the reporting period ===================== UBS Select Government Investor Fund ====================== Did not vote any securities during the reporting period ===================== UBS Select Government Preferred Fund ===================== Did not vote any securities during the reporting period ===================== UBS Select Prime Institutional Fund ====================== Did not vote any securities during the reporting period ======================== UBS Select Prime Investor Fund ======================== Did not vote any securities during the reporting period ======================= UBS Select Prime Preferred Fund ======================== Did not vote any securities during the reporting period ==================== UBS Select Treasury Institutional Fund ==================== Did not vote any securities during the reporting period ====================== UBS Select Treasury Investor Fund ======================= Did not vote any securities during the reporting period ====================== UBS Select Treasury Preferred Fund ====================== Did not vote any securities during the reporting period ========================== UBS Tax-Free Investor Fund ========================== Did not vote any securities during the reporting period ========================= UBS Tax-Free Preferred Fund ========================== Did not vote any securities during the reporting period ========================== UBS Tax-Free Reserves Fund ========================== Did not vote any securities during the reporting period ========================= UBS Ultra Short Income Fund ========================== Did not vote any securities during the reporting period Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. UBS Series Funds Igor Lasun * President UBS Series Funds Managing Director UBS Asset Management (Americas) Inc. ========== END NPX REPORT
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| (Registrant) | UBS Series Funds | ||
| By (Signature and Title)* | /s/ Igor Lasun*, President | ||
| Igor Lasun | |||
| *(Signature affixed by Eric Sanders by Power of Attorney effective July 20, 2023 and filed herewith). | |||
| Date | August 23, 2023 | ||
*Print the name and title of each signing officer under his or her signature.
UBS Investment Trust
UBS Series Funds
PACE Select Advisors Trust
Master Trust
The UBS Funds
SMA Relationship Trust
Power of Attorney
Igor Lasun, whose signature appears below, does hereby constitute and appoint Keith Weller and Eric Sanders, each an officer of the above named investment companies (each hereafter the "Company") individually with power of substitution or resubstitution, his true and lawful attorney-in-fact and agent ("Attorney-in-Fact") with full power of substitution and resubstitution for him in his name, place and stead, in any and all capacities, to file with the Securities and Exchange Commission the Company's proxy voting record on Form N-PX with all exhibits and any amendments thereto, and sign Form N-PX and any amendments thereto in the name and on behalf of the undersigned as President and/or principal executive officer of the Company any and any other instruments or documents related thereto, and the undersigned does hereby ratify and confirm all that said Attorney-in-Fact shall do or cause to be done by virtue thereof.
This Power of Attorney shall be revocable at any time by a writing signed by the undersigned and shall terminate automatically with respect to the Attorney-in-Fact named above if such Attorney-in-Fact ceases to be an officer of the Company and with respect to the Attorney-in-Fact named above if the undersigned ceases to be President and/or principal executive officer of the Company.
Effective Date:
July 20, 2023
| By: | /s/ Igor Lasun | |
| Igor Lasun | ||
| President |